Annual Operating Expenses
$77.38 M
+$2.81 M+3.77%
December 31, 2023
Summary
- As of February 27, 2025, BDSX annual total operating expenses is $77.38 million, with the most recent change of +$2.81 million (+3.77%) on December 31, 2023.
- During the last 3 years, BDSX annual operating expenses has risen by +$31.70 million (+69.40%).
- BDSX annual operating expenses is now at all-time high.
Performance
BDSX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$22.56 M
+$345.00 K+1.55%
September 30, 2024
Summary
- As of February 27, 2025, BDSX quarterly total operating expenses is $22.56 million, with the most recent change of +$345.00 thousand (+1.55%) on September 30, 2024.
- Over the past year, BDSX quarterly operating expenses has increased by +$5.13 million (+29.42%).
- BDSX quarterly operating expenses is now -0.15% below its all-time high of $22.60 million, reached on March 31, 2024.
Performance
BDSX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
BDSX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.8% | +29.4% |
| 3 y3 years | +69.4% | +29.4% |
| 5 y5 years | +127.0% | +29.4% |
BDSX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +22.2% | -0.1% | +37.5% |
| 5 y | 5-year | at high | +88.2% | -0.1% | +152.3% |
| alltime | all time | at high | +127.0% | -0.1% | +152.3% |
Biodesix Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $22.56 M(+1.6%) |
| Jun 2024 | - | $22.22 M(-1.7%) |
| Mar 2024 | - | $22.60 M(+24.6%) |
| Dec 2023 | $77.38 M(+3.8%) | $18.14 M(+4.0%) |
| Sep 2023 | - | $17.43 M(-10.9%) |
| Jun 2023 | - | $19.56 M(-12.0%) |
| Mar 2023 | - | $22.24 M(+10.1%) |
| Dec 2022 | $74.56 M(+17.8%) | $20.19 M(+11.7%) |
| Sep 2022 | - | $18.08 M(-2.8%) |
| Jun 2022 | - | $18.60 M(+5.1%) |
| Mar 2022 | - | $17.69 M(+7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $63.31 M(+38.6%) | $16.41 M(-2.9%) |
| Sep 2021 | - | $16.90 M(+14.6%) |
| Jun 2021 | - | $14.75 M(-3.3%) |
| Mar 2021 | - | $15.25 M(+0.5%) |
| Dec 2020 | $45.67 M(+11.1%) | $15.17 M(+43.3%) |
| Sep 2020 | - | $10.59 M(+18.4%) |
| Jun 2020 | - | $8.94 M(-18.6%) |
| Mar 2020 | - | $10.98 M(+21.2%) |
| Dec 2019 | $41.10 M(+20.6%) | $9.06 M(-14.3%) |
| Sep 2019 | - | $10.57 M |
| Dec 2018 | $34.09 M | - |
FAQ
- What is Biodesix annual total operating expenses?
- What is the all time high annual operating expenses for Biodesix?
- What is Biodesix annual operating expenses year-on-year change?
- What is Biodesix quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Biodesix?
- What is Biodesix quarterly operating expenses year-on-year change?
What is Biodesix annual total operating expenses?
The current annual operating expenses of BDSX is $77.38 M
What is the all time high annual operating expenses for Biodesix?
Biodesix all-time high annual total operating expenses is $77.38 M
What is Biodesix annual operating expenses year-on-year change?
Over the past year, BDSX annual total operating expenses has changed by +$2.81 M (+3.77%)
What is Biodesix quarterly total operating expenses?
The current quarterly operating expenses of BDSX is $22.56 M
What is the all time high quarterly operating expenses for Biodesix?
Biodesix all-time high quarterly total operating expenses is $22.60 M
What is Biodesix quarterly operating expenses year-on-year change?
Over the past year, BDSX quarterly total operating expenses has changed by +$5.13 M (+29.42%)